the use of flurbiproph u00e8ne and ibuprofen, and their pharmaceutically acceptable salts and esters in a process for increasing bone mass and for treating and preventing bone mass loss, with the exception of reducing or increasing the mass osse use).the invention relates more particularly to ...
To update the 2000 ASCO guidelines on the role of bisphosphonates in women with breast cancer and address the subject of bone health in these women.For pat... Hillner,E B. - 《Journal of Clinical Oncology Official Journal of the American Society of Clinical Oncology》 被引量: 2005发表: 200...
BEIJING, Aug. 25 (Xinhua) -- Chinese scientists have developed a non-invasive technique with the help of magnetic energy that holds promise for preventing bone loss in cancer patients under radiotherapy. The study published on Thursday in the journal Science Advances reported that the pulsed-burst...
SHANGHAI, March 18 (Xinhua) -- A Chinese research team has developed a multicellular scaffold based on inorganic bioceramics for treating tendon-to-bone injuries. Restriction of motor activity due to loss of natural structure is a major cause of decreased life quality in patients suffering from t...
demonstrate the potential utility of NELL-1 as a combination anabolic/antiosteoclastic therapeutic for bone loss. Similar content being viewed by others Inducible expression of Wnt7b promotes bone formation in aged mice and enhances fracture healing...
A method for the treatment of osteoporosis, Paget's disease of bone, hyperparathyroidism, malignant neoplasms causing hypercalcinemia, parodontal diseases and implant-related bone loss comprising administration to a patient suffering therefrom an amount of a compound of formula (I), or a prodrug or...
Impact of fixation method on femoral bone loss: a retrospective evaluation of stem loosening in first-time revision total hip arthroplasty among two hundre... Purpose: Implant loosening represent the most common indication for stem revision in hip revision arthroplasty. This study compares femoral bon...
Finally, systemic admin- istration of NELL-1 was used to reverse gonadectomy-induced osteoporotic bone loss in mice. In sum, the present study describes a new role for NELL-1 as an aetiological factor and a treatment of osteoporosis. Results Osteoporotic phenotype of Nell-1-haploinsufficient ...
A decrease in hormones, in estrogen- and progesterone-positive and -negative patients, introduces an environment for decreased bone remodeling, which may result in thinning bone and osteoporosis. The acceleration of bone loss leading to osteoporosis can result in higher fracture rates among breast ...
infections within the last decade, challenges remain in clinical management. The development and application of tissue engineering materials have provided new strategies for the treatment of bone infections, but a comprehensive review of their research progress is lacking. This review discusses the ...